All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervicitis-21436703
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 21436703 C172S
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
2 21436703 D105G
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
3 21436703 F109V
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
4 21436703 H228D
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
5 21436703 L103F
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
6 21436703 N108P
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
7 21436703 P104K
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
8 21436703 P104S
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
9 21436703 P104Y
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
10 21436703 P106S
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
11 21436703 T292A
L1
L1
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
12 21436703 G666A
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
13 21436703 N29H
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
14 21436703 N29S
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
15 21436703 T846C
E7
E7
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
16 21436703 D25E
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
17 21436703 E113D
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
18 21436703 H78Y
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
19 21436703 L83V
E6
E6
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
G
R
C
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.